2022
DOI: 10.1371/journal.pone.0266331
|View full text |Cite
|
Sign up to set email alerts
|

Ganoderma tsugae prevents cognitive impairment and attenuates oxidative damage in d-galactose-induced aging in the rat brain

Abstract: Lingzhi has long been regarded as having life-prolonging effects. Research in recent years has also reported that Lingzhi possesses anti-tumor, anti-inflammatory, immunomodulatory, hepatoprotective, and anti-lipogenic effects. The D-galactose (D-gal, 100 mg/kg/day)-induced aging Long-Evans rats were simultaneously orally administered a DMSO extract of Ganoderma tsugae (GTDE, 200 μg/kg/day) for 25 weeks to investigate the effects of GTDE on oxidative stress and memory deficits in the D-galactose-induced aging r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 80 publications
1
9
0
Order By: Relevance
“…Similar to this, animals treated with D-gal had their Frontiers in Molecular Biosciences frontiersin.org brain GPx and GST activities significantly reduced (El-Far et al, 2022). Also, SOD1 protein (Kuo et al, 2022) and SOD activity (Kuo et al, 2022) were decreased in the brain of rats injected with D-gal. Significant drops in the levels of Sirt1, Bcl2, CAT, and GPx were reported by Motevalian et al (2021) in D-gal-treated mice.…”
Section: Molecular Dockingsupporting
confidence: 71%
“…Similar to this, animals treated with D-gal had their Frontiers in Molecular Biosciences frontiersin.org brain GPx and GST activities significantly reduced (El-Far et al, 2022). Also, SOD1 protein (Kuo et al, 2022) and SOD activity (Kuo et al, 2022) were decreased in the brain of rats injected with D-gal. Significant drops in the levels of Sirt1, Bcl2, CAT, and GPx were reported by Motevalian et al (2021) in D-gal-treated mice.…”
Section: Molecular Dockingsupporting
confidence: 71%
“…We divided the animals into four groups as follows: Control (Control), GT treatment (GT), d -galactose ( d -gal) treatment (aging), and d -gal plus GT treatment (aging + GT). In the d -gal treatment group, we subcutaneously administered daily d -gal injections (100 mg/kg) 28 to the mice for eight weeks. In the d -gal plus GT treatment group, GT (200 μg/kg) 28 was administered as oral gavage daily concomitantly with D-gal injections for eight weeks.…”
Section: Methodsmentioning
confidence: 99%
“…In the d -gal treatment group, we subcutaneously administered daily d -gal injections (100 mg/kg) 28 to the mice for eight weeks. In the d -gal plus GT treatment group, GT (200 μg/kg) 28 was administered as oral gavage daily concomitantly with D-gal injections for eight weeks. All control animals were subcutaneously administered phosphate-buffered saline at equal volumes.…”
Section: Methodsmentioning
confidence: 99%
“…45 recognized significant decreases in brain GPx and GST activities in d -gal-treated rats. Also, d -gal decreased the protein expression of SOD1 56 and SOD 57 activity in the brain of rats. Similarly, Motevalian et al 51 stated significant decreases in the expression of Sirt1, Bcl2, CAT, and GPx of d -gal-treated mice.…”
Section: Discussionmentioning
confidence: 91%